{"id":"W3169630256","doi":"10.1200/jco.2021.39.15_suppl.e16183","title":"A phase I study of nivolumab (NIVO) in combination with TheraSphere (Yttrium-90) in patients with advanced hepatocellular cancer.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Nivolumab; Internal medicine; Hepatocellular carcinoma; Oncology; Phases of clinical research; Combination therapy; Cancer; Gastroenterology; Clinical trial; Immunotherapy","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001554202,0.001527374,0.001993568,0.0004973796,0.0004353476,0.0009730277,0.0008041169,0.0009890551,0.002103568],"category_scores_gemma":[0.0007210087,0.0007288071,0.001148982,0.0004626785,0.001094108,0.000821461,0.0004182854,0.002409089,0.000750903],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009875271,"about_ca_system_score_gemma":0.001885192,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00109659,"about_ca_topic_score_gemma":0.002171926,"domain_scores_codex":[0.9995322,0.0002296484,0.00002514795,0.00007198892,0.00004397582,0.00009704033],"domain_scores_gemma":[0.999329,0.00009669536,0.0001004285,0.00005527856,0.00004025231,0.0003784348],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6833984,0.1528837,0.01302669,0.0009588465,0.001405454,0.0004193727,0.000606503,0.003800367,0.05491556,0.0003229501,0.002621057,0.085641],"study_design_scores_gemma":[0.3664885,0.6172323,0.00875083,0.00002361011,0.0002925705,0.0002414594,0.00008552936,0.001063483,0.003587958,0.0001180869,0.002089304,0.00002634878],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946437,0.001184838,0.0003822353,0.0002297577,0.00009957415,0.002117184,0.0004350826,0.00004635988,0.0008612669],"genre_scores_gemma":[0.9922225,0.001113141,0.001437646,0.0003852062,0.0001374737,0.002174045,0.001005227,0.00002154988,0.001503291],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002103568,"threshold_uncertainty_score":0.00821954,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1072159739858046,"score_gpt":0.4048920208627741,"score_spread":0.2976760468769695,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}